Health care ANALYTICS

FOR THE GLOBAL BIOPHARMACEUTICAL & MEDICAL DEVICE INDUSTRIES

image description

Plexus

Health care Network analytics

Plexus™ uses disease-specific patient encounter data to detect interpersonal influence among community-based health care providers and identify impactful provider influence networks.

Acuity

Stakeholder Management System

81qd’s online stakeholder management solution, Acuity™, helps biopharmaceutical companies optimize the value of engagements with advanced analytics and proprietary, technology-enabled identification and profiling techniques.

In the news

In the news

Early Diagnosis of a Rare Disease

In the world of rare diseases it has been said that, “a disease isn’t rare, it’s just rarely diagnosed.” And there’s the rub with properly managing patients with rare diseases. In recent years, the number of FDA approvals for therapies to treat rare disorders has steadily increased; nearly half of all novel drugs approved in 2015 are indicated for a rare disease. Yet, while 1 in 10 Americans are afflicted with a rare condition, it often takes several years for a patient with a rare disease to receive a proper diagnosis. 

In the news

Easing Payer Pressure with Analytics

The 2016 Medical Marketing & Media (MM&M) Healthcare Marketers Trend Report produced two findings that, given the current state of the industry, are not all that surprising, but they are nevertheless intriguing. Payer/Managed Care Pressure was cited as the top challenge to healthcare marketers by the 181 director-level-and-above executives of pharma, biotech, device and diagnostics companies who were surveyed. On the other hand, Big Data topped the list of opportunities perceived by the executives of medium to large companies.

In the news

Thinking Through Thought Leader Relationships

The relationship between pharma companies and health care providers continues to be under scrutiny. The Physician Payments Sunshine Act in the U.S. and the European Federation of Pharmaceutical Industries and Associations (EFPIA) code on transfers of value require biopharmaceutical companies to publicly report payments to health care providers. These laws are intended to increase the transparency of relationships and disclose potential conflicts of interest.

Request a demo today

image description

Turn data into actionable insights with our health care analytics platforms, Plexus™, Acuity™ and Orion™. Contact us today to demo our platforms.